Valneva, Pfizer push back timeline for Lyme disease vaccine

[cafead]

via Pfizer and its partner Valneva, a France-based vaccine maker, have pushed back when they expect to submit an approval application for their experimental Lyme disease shot from 2025 to 2026, according to an earnings statement Thursday.

article source